Feedback / Questions
Ebglyss (lebrikizumab-lbkz) - Eli Lilly
Seysara (sarecycline) - Novo Holdings, Almirall
Ilumya (tildrakizumab-asmn) - Sun Pharma, Almirall
Klisyri (tirbanibulin ointment) - Hanmi, Almirall, Athenex, PharmaEssentia
ALM27134 - Almirall
https://www.businesswire.com/news/home/20250223477772/en/Almirall-2024-Full-Year-Results-Almirall-Surpassed-Guidance-for-2024---Entering-an-Era-of-Sustained-Growth-and-Further-Advancing-Its-Medical-Dermatology-Pipeline
Feb 24, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next